ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Pitt Inquiry Panel Proceedings Suspended, ORI To Take Over NSABP Investigation

July 22, 1994

Medicare Coverage For Clinical Trials Tops NBCC Agenda

January 30, 1998

Eight applications Received For NSABP chairman

September 9, 1994

Professional Societies: ASCO Seeks Balance In Roles As U.S., International Society

May 23, 1997

Clinical Practice Guidelines Don’t Meet IOM Standards

June 26, 2013

NCI Says Review Group Will Read Blueprint, Evaluate NCI Research

January 16, 1998